GlassScriptPhysician profile
Abrea A Roark
NPI 1508156613
$4,775.75
in general payments reported to CMS, 2019-2025
12 companies · $36.61 in 2025
The $36.61 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,611 · 2020: $40.20 · 2022: $16.97 · 2023: $36.19 · 2024: $34.30 · 2025: $36.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,554.22 | 2019 | |
| Daiichi Sankyo INC. | $31.19 | 2020-2023 | Injectafer |
| Merck Sharp & Dohme LLC | $26.05 | 2019 | |
| Coopersurgical, INC. | $25.99 | 2020 | |
| Pelvital USA, INC. | $22.66 | 2025 | |
| Exeltis, USA INC. | $19.53 | 2024 | Slynd |
| Astellas Pharma US INC | $19.21 | 2023 | Veozah |
| Myovant Sciences INC. | $16.97 | 2022 | |
| Hologic Sales and Service, LLC | $16.20 | 2019 | |
| Mallinckrodt Enterprises LLC | $15.01 | 2019 | |
| Organon LLC | $14.77 | 2024 | |
| Dexcom, INC. | $13.95 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abrea Roark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.